Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiqi Su

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
BMJ Open|January 6, 2022
Effects of hyperuricaemia, with the superposition of being overweight and hyperlipidaemia, on the incidence of acute kidney injury following cardiac surgery: a retrospective cohort studyYiqi Su, Haoxuan Li, Yang Li, et al.
Transplantation and Cellular Therapy|June 5, 2024
Impact of Primary Letermovir Prophylaxis Versus Preemptive Antiviral Therapy for Cytomegalovirus on Economic and Clinical Outcomes after Hematopoietic Cell TransplantationCarrie A Tan, Lauren Palen, Yiqi Su, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2020
A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell TransplantationAnat Stern, Yiqi Su, Yeon Joo Lee, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 22, 2025
Magnesium Lithospermate B Protects Against Ischemic AKI-to-CKD progression via regulating the KLF5/CDK1/Cyclin B1 pathwayLiyu Lin, Daoqi Shen, Yiqi Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2022
Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort StudyYiqi Su, Anat Stern, Eleni Karantoni, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 5, 2019
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experienceAndrew Lin, Molly Maloy, Yiqi Su, et al.
Bioactive Materials|July 2, 2026
Immunity-and-matrix-regulatory cells promote hyaline-like cartilage repair in osteoarthritisYiqi Su, Zihao He, Kai Wang, et al.
The Journal of Clinical Investigation|March 23, 2023
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplantSusan E Prockop, Aisha Hasan, Ekaterina Doubrovina, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
BMJ Open|January 6, 2022
Effects of hyperuricaemia, with the superposition of being overweight and hyperlipidaemia, on the incidence of acute kidney injury following cardiac surgery: a retrospective cohort studyYiqi Su, Haoxuan Li, Yang Li, et al.
Transplantation and Cellular Therapy|June 5, 2024
Impact of Primary Letermovir Prophylaxis Versus Preemptive Antiviral Therapy for Cytomegalovirus on Economic and Clinical Outcomes after Hematopoietic Cell TransplantationCarrie A Tan, Lauren Palen, Yiqi Su, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2020
A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell TransplantationAnat Stern, Yiqi Su, Yeon Joo Lee, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 22, 2025
Magnesium Lithospermate B Protects Against Ischemic AKI-to-CKD progression via regulating the KLF5/CDK1/Cyclin B1 pathwayLiyu Lin, Daoqi Shen, Yiqi Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2022
Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort StudyYiqi Su, Anat Stern, Eleni Karantoni, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 5, 2019
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experienceAndrew Lin, Molly Maloy, Yiqi Su, et al.
Bioactive Materials|July 2, 2026
Immunity-and-matrix-regulatory cells promote hyaline-like cartilage repair in osteoarthritisYiqi Su, Zihao He, Kai Wang, et al.
The Journal of Clinical Investigation|March 23, 2023
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplantSusan E Prockop, Aisha Hasan, Ekaterina Doubrovina, et al.
Pageof 4